CLINICAL_TRIALS
trial_result
· 2012-02-13
Clinical Trial Update: Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications [Phase 4]
Summary
Phase 4 study comparing tolerability of clindamycin 1% with benzoyl peroxide 5% gel versus clindamycin 1.2% with benzoyl peroxide 2.5% topical in acne vulgaris;…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2012-02-13